Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures.
Lapi F, Cipriani F, Caputi AP, Corrao G, Vaccheri A, Sturkenboom MC, Di Bari M, Gregori D, Carle F, Staniscia T, Vestri A, Brandi M, Fusco V, Campisi G, Mazzaglia G; Bisphosphonates Efficacy-Safety Tradeoff (BEST) study group. Lapi F, et al. Osteoporos Int. 2013 Feb;24(2):697-705. doi: 10.1007/s00198-012-2013-y. Epub 2012 May 23. Osteoporos Int. 2013. PMID: 22618266
Risk of severe upper gastrointestinal complications among oral bisphosphonate users.
Ghirardi A, Scotti L, Zambon A, Della Vedova G, Cavalieri D'oro L, Lapi F, Cipriani F, Caputi AP, Vaccheri A, Gregori D, Gesuita R, Vestri A, Staniscia T, Mazzaglia G, Corrao G; BEST Investigators. Ghirardi A, et al. Among authors: lapi f. PLoS One. 2013 Dec 9;8(12):e73159. doi: 10.1371/journal.pone.0073159. eCollection 2013. PLoS One. 2013. PMID: 24348985 Free PMC article.
Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study.
Herrera L, Leal I, Lapi F, Schuemie M, Arcoraci V, Cipriani F, Sessa E, Vaccheri A, Piccinni C, Staniscia T, Vestri A, Di Bari M, Corrao G, Zambon A, Gregori D, Carle F, Sturkenboom M, Mazzaglia G, Trifiro G. Herrera L, et al. Among authors: lapi f. Osteoporos Int. 2015 May;26(5):1499-506. doi: 10.1007/s00198-014-3020-y. Epub 2015 Mar 10. Osteoporos Int. 2015. PMID: 25752621 Free PMC article.
Oral bisphosphonates do not increase the risk of severe upper gastrointestinal complications: a nested case-control study.
Ghirardi A, Scotti L, Vedova GD, D'Oro LC, Lapi F, Cipriani F, Caputi AP, Vaccheri A, Gregori D, Gesuita R, Vestri A, Staniscia T, Mazzaglia G, Corrao G; AIFA-BEST Investigators. Ghirardi A, et al. Among authors: lapi f. BMC Gastroenterol. 2014 Jan 7;14:5. doi: 10.1186/1471-230X-14-5. BMC Gastroenterol. 2014. PMID: 24397769 Free PMC article.
Effectiveness of oral bisphosphonates for primary prevention of osteoporotic fractures: evidence from the AIFA-BEST observational study.
Ghirardi A, Di Bari M, Zambon A, Scotti L, Della Vedova G, Lapi F, Cipriani F, Caputi AP, Vaccheri A, Gregori D, Gesuita R, Vestri A, Staniscia T, Mazzaglia G, Corrao G; BEST investigators. Ghirardi A, et al. Among authors: lapi f. Eur J Clin Pharmacol. 2014 Sep;70(9):1129-37. doi: 10.1007/s00228-014-1708-8. Epub 2014 Jun 22. Eur J Clin Pharmacol. 2014. PMID: 24951915
Comparative cardiovascular safety of strontium ranelate and bisphosphonates: a multi-database study in 5 EU countries by the EU-ADR Alliance.
Ali MS, Berencsi K, Marinier K, Deltour N, Perez-Guthann S, Pedersen L, Rijnbeek P, Lapi F, Simonetti M, Reyes C, Van der Lei J, Sturkenboom M, Prieto-Alhambra D. Ali MS, et al. Among authors: lapi f. Osteoporos Int. 2020 Dec;31(12):2425-2438. doi: 10.1007/s00198-020-05580-0. Epub 2020 Aug 5. Osteoporos Int. 2020. PMID: 32757044
Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance.
Berencsi K, Sami A, Ali MS, Marinier K, Deltour N, Perez-Gutthann S, Pedersen L, Rijnbeek P, Van der Lei J, Lapi F, Simonetti M, Reyes C, Sturkenboom MCJM, Prieto-Alhambra D. Berencsi K, et al. Among authors: lapi f. Osteoporos Int. 2020 Apr;31(4):721-755. doi: 10.1007/s00198-019-05181-6. Epub 2019 Nov 6. Osteoporos Int. 2020. PMID: 31696274
Correction to: Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance.
Berencsi K, Sami A, Ali MS, Marinier K, Deltour N, Perez-Gutthann S, Pedersen L, Rijnbeek P, Van der Lei J, Lapi F, Simonetti M, Reyes C, Sturkenboom MCJM, Prieto-Alhambra D. Berencsi K, et al. Among authors: lapi f. Osteoporos Int. 2020 Apr;31(4):799. doi: 10.1007/s00198-020-05314-2. Osteoporos Int. 2020. PMID: 32025756
189 results